A study of 14 million children showed that COVID-19 increases the risk of inflammatory heart disease in children by 17 cases, while Pfizer/BioNTech mRNA vaccination reduces this risk. Vaccinated children have a lower risk of myocarditis than unvaccinated children, despite a rare side effect of vaccines.
The surge in incidence of the new "Frankenstein" coronavirus variant in Ukraine passed back in August, and it is already losing activity. According to virologist Alla Myronenko, COVID-19 is seasonal and does not pose a serious threat.
A large-scale study has shown that repeated COVID-19 infection significantly increases the risk of long-term consequences in children. After the first infection, long COVID was recorded in 904 children per million, and after reinfection, this figure rose to 1884 children per million.
The number of new COVID-19 cases in Ukraine decreased by 20. 4% in a week, to 11,883. 19 deaths were registered.
Kyiv recorded a 17. 9% decrease in COVID-19 incidence over the week, with 1080 people infected. Hospitalizations also decreased to 89 people, but cases of the new Stratus (XFG) strain were recorded.
Japanese scientists have identified four types of the body's reaction to COVID-19 vaccines using artificial intelligence. The study showed that people with high initial antibody levels that rapidly decline are at the highest risk of infection.
Over the week, 14,926 cases of COVID-19 were registered in Ukraine, which is 3. 5% more than the previous week. 19 deaths were recorded, with fewer cases in the four weeks of 2025 than in the same period last year.
The number of COVID-19 cases is increasing in Ukraine, with 10,622 cases recorded in the 35th week of 2025. Local authorities decide on anti-epidemic measures, including the mask mandate.
During the 36th week of 2025, 14,414 new cases of COVID-19 were registered in Ukraine, which is 32. 3% more than the previous week. Also, 21 fatal cases were detected.
In Ukraine, 10,622 cases of COVID-19 were recorded last week, which is 46. 2% more than the previous week. 14 deaths were registered, with further growth expected.
US President Donald Trump called on pharmaceutical companies to justify the effectiveness of COVID vaccines amid unrest at the CDC. He demands that they publicly show the results of their work.
In Ukraine, 125 cases of the COVID-19 "Stratus" strain and three cases of the "Nimbus" strain have been recorded. These strains spread more easily among youth and children but do not cause severe illness.
Last year, mortality from COVID-19 and the flu was almost the same. However, COVID-19 has a higher fatality rate with fewer people infected.
Deputy Minister of Health Ihor Kuzin stated that regions have mechanisms for introducing local quarantines. This is possible with a significant excess of the average COVID-19 incidence rate.
Deputy Minister of Health Ihor Kuzin predicts an increase in COVID-19 incidence in late September – early October. Restrictive measures and lockdown are unlikely, as the indicators are significantly lower than last year.
In Kyiv, a 1. 6-fold increase in COVID-19 incidence was recorded over the week. 1121 cases were registered, 117 people were hospitalized, 57 of whom were children.
An increase in the number of COVID-19 cases has been recorded in Ukraine, but the incidence rate in August 2025 is three times lower than in August 2024. The highest number of cases has been detected in Kyiv, Dnipropetrovsk, and Lviv regions, as well as in Kyiv Oblast.
Deputy Minister of Health Ihor Kuzin said that the current wave of COVID-19 will last until the end of September. Currently, there are no grounds for introducing quarantine restrictions in any region.
The study found that SARS-CoV-2 infection is associated with increased arterial stiffness in women, especially in severe cases of the disease. This effect was not observed in men, which may explain the prolonged course of COVID-19 in women.
A new coronavirus strain, "Stratus," has been detected in Ukraine, characterized by hoarseness and prolonged sore throat. It exhibits typical COVID-19 symptoms but requires attention for at-risk groups.
The number of hospitalizations for COVID-19 is increasing in Kyiv, including severe cases. This is due to the seasonal surge in incidence and people returning from vacation.
38 cases of the new coronavirus strain Stratus have been recorded in Ukraine. It demonstrates an increased ability to spread, but does not lead to a more severe course of the disease.
A new, rapidly spreading coronavirus variant XFG (Stratus) has been detected in the Poltava region. It does not cause a more severe course of the disease but may manifest as hoarseness.
A new Covid strain, Stratus, is spreading in the UK, featuring a unique symptom – hoarseness of voice. Variants XFG and XFG.3 account for about 30% of Covid-19 cases in England, but do not cause more severe illness.
The circulation of the new COVID-19 strain "Nimbus" has not yet been recorded in Ukraine, but there is a possibility of its appearance due to active migration processes. The incidence of COVID-19 in Ukraine does not significantly affect the course of the epidemic process of acute respiratory viral infections.
The new COVID Nimbus strain (NB. 1.8.1) is spreading rapidly around the world. Doctors say it has a distinctive symptom - severe sore throat, known as a "razor blade sensation".
The European Union plans to end funding for the COVID recovery fund, which was supposed to last until the end of 2026. This puts Italy, Spain and Poland, which are most dependent on these funds, at risk.
The US Minister of Health announced that COVID-19 vaccines are no longer recommended for healthy children and pregnant women. The CDC Advisory Group will meet in June to develop recommendations.
The epidemic season 2024/2025 has officially ended. More than 4.6 million Ukrainians have had acute respiratory viral infections, more than half of them children, and the incidence of COVID-19 has decreased by 7.4 times.
International researchers have found a gene variant near the FOXP4 gene that increases the risk of long-term COVID-19 by 60% and affects lung function. This may explain shortness of breath, fatigue and cognitive problems.
